KDP
Keurig Dr Pepper
Data as of 2026-09-05
Company attributes
Price
Interactive 5-year price history chart for KDP. Latest close $32.88.
Pillar breakdown
0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)
- QualityProfit margins & asset efficiency24PoorConsumer Staples median (n=76) 47
- ValuePrice vs fundamentals36WeakConsumer Staples median (n=76) 51
- GrowthRevenue & earnings trajectory44AverageConsumer Staples median (n=76) 49
- MomentumRecent price strength56StrongConsumer Staples median (n=76) 45
- HealthBalance sheet & solvency18PoorConsumer Staples median (n=76) 40
- ProfitabilityROE, ROA, ROIC43AverageConsumer Staples median (n=76) 48
- TechnicalTrend & volatility signals72ExceptionalConsumer Staples median (n=76) 51
- RiskVolatility & drawdown profile66StrongConsumer Staples median (n=76) 51
Pillars not shown: Sentiment, ML (Phase 5+).
Risk Summary
1 active- Altman financial distress[altman_distress]Altman Z″ below 1.10 — financial-distress zone (Altman 1968).
These flags keep the raw composite rank (project Rule 16) but forfeit the entered_top5 badge. Two of them — altman_distress and data_quality_input_corruption — additionally force a cautious recommendation; the others act as Top-5 disqualifiers without dictating the buy/hold/sell label on their own.
- Beneish M-score warning band[beneish_high]
Rolls up Phase 4.5 earnings-manipulation defenses (Sloan · Beneish · Dechow · REM · restatement · late-filing · earnings- quality time-series) into a single 0-100 risk index. The soft composite penalty (max 10 pts) is informational only — the ranking uses the raw composite score per project Rule 16.
Fair price check
4 different valuation methods each estimate what KDP should be worth, then we compare to today's price.
- P/B multiplesUndervaluedthinks it's a bargain — estimates $56.35, about 71% above today
- P/E multiplesOvervaluedthinks it's expensive — estimates $27.60, about 16% below today
- EV/EBITDAOvervaluedthinks it's expensive — estimates $22.96, about 30% below today
- DCF (2-stage)Outlierestimate looks unreliable — estimates $2.18 — likely unreliable
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
- Median fair
- $25.28
- Margin of safety(vs fair value)
- -30.1%
- Max (ex-outliers)
- $56.35
- Tangible BVPS
- —
- Extreme DCF estimate
- Beneish M-score (warning band)
Median of all applicable methods (current price $32.88). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.
Supporting dataRaw fundamentals & data-quality provenance behind the scores above
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $44.74B |
| Revenue (TTM) | $20.09B |
| Net income (TTM) | $1.64B |
| Operating cash flow (TTM) | $2.53B |
| CapEx (TTM) | $557.00M |
| Free cash flow (TTM)CFO − CapEx | $1.97B |
| Total assets | $87.62B |
| Total liabilities | $53.97B |
| Stockholders' equity | $25.03B |
| Cash & equivalents | $1.52B |
| Shares outstanding | 1.36B |
| EPS (basic) | $1.21 |
| EPS (diluted) | $1.21 |
| P/E ratio (TTM) | 27.23 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-08-10
- Latest period end
- 2026-08-10
- Filing lag
- 26 days
- Missing metrics
- 2(research_and_development, interest_expense)
Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.